Investment
Elucid Raises $55M to Expand AI Cardiovascular Diagnostics
Elucid Raises $55M Series D Funding Boston-based medical technology company Elucid has raised $55 million in fresh funding. The company secured the capital through an oversubscribed Series D financing round. The round brings its total funding to approximately $185 million. A large medtech company joined the round as a…
VentureburnBy Clinton
Share

Read the full story
Africa Business Review aggregates and summarises reporting from trusted publishers. The full article is published by Ventureburn.
Read at Ventureburn →Original headline: “Elucid Raises $55M to Expand AI Cardiovascular Diagnostics”
- News
- Startup
- Venture Capital